110 results
Page 2 of 6
8-K
EX-99.1
gn3bbngnmof6kx4o
3 Aug 21
Alnylam Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights
8:10am
8-K
EX-99.1
1qgbzutz05l5x
29 Apr 21
Results of Operations and Financial Condition
8:12am
8-K
EX-99.1
jy75542l2n 822
11 Feb 21
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
are9hry3w nmp
11 Jan 21
Alnylam Launches “Alnylam P5x25” Strategy for Planned Transition to a Top Five Biotech in Market Capitalization Over Next Five Years
8:37am
8-K
EX-99.1
1111rlqb
5 Nov 20
Results of Operations and Financial Condition
8:10am
8-K
EX-99.2
ydueujn58q2uj2klzvdq
6 Aug 20
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
5rsghbhsc1m4z0k7
6 Aug 20
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
p7un3
6 May 20
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
gab0zpsns0eeg8eiwr2
13 Apr 20
Blackstone and Alnylam Enter Into $2 Billion Strategic Financing Collaboration to
4:22pm
8-K
EX-99.1
fth 3uijq16shdj
6 Feb 20
Results of Operations and Financial Condition
8:28am
8-K
EX-99.1
q86m0jgk
31 Oct 19
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
ou664zffk
6 Aug 19
Results of Operations and Financial Condition
8:15am
8-K
EX-99.1
kiu7n2eonj 3vx3hw11
1 May 19
Alnylam Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Period Activity
8:45am
8-K
EX-99.1
kftzdf6ad1l7vqb
7 Feb 19
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Recent Period Activity
4:15pm
424B5
sf450w vyllx3a
15 Jan 19
Prospectus supplement for primary offering
5:14pm